Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynergia Energy Regulatory News (SYN)

Share Price Information for Synergia Energy (SYN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.1125
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.01 (9.091%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.1125
SYN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Restatement of Accounts

25 Apr 2019 07:00

RNS Number : 0119X
Synnovia PLC
25 April 2019
 

25th April 2019

 

Synnovia plc

("Synnovia" or the "Group")

 

Trading Update and Restatement of Accounts

 

Trading Update

 

Further to its trading update announced on 19 February 2019, Synnovia (AIM: SYN) announces that it expects results for the financial year ended 31 March 2019 to show significant growth in both sales and profits albeit, while up significantly, profits are expected to be marginally below current market expectations.

 

Overall, we experienced another year of strong sales and profit growth. Our Industrial Division, led by the bearings business, has performed extremely well as new business came on stream after the unexpected delays we reported in the prior year. This performance was supported by the acquisitions completed during the past three years in the creasing matrix business, which have continued to show good improvement.

 

As previously reported, our Films Division has continued to grow both sales and customers despite becoming capacity constrained mid-year due to some relatively minor project delays in planned expansion within the division. Whilst new capacity came on stream in early calendar year 2019, it was too late to enable performance to recover fully before the financial year came to an end.

 

Profitability in the Films Division was adversely affected by these project delays, with the Group having incurred costs to meet anticipated sales growth. In addition, there has been some modest cost inflation in energy, packaging and logistics. None of these factors have applied to the Industrial Division, where margins and costs increases have been in line with expectations.

 

We have continued to invest heavily to add capacity and capabilities to support the sales and profit growth being achieved. Naturally this impacts depreciation costs, interest costs and cash flow in the near term. We are confident that these investments will continue to benefit shareholders over the longer run.

 

Restatement of Historic Accounts

 

The Group also reports that, while there is no effect on reported profitability, it has recently discovered a non-material overstatement of revenue for the financial year ended 31 March 2018. The overstatement amounts to £1.619 million, which represents circa 2% of reported revenues, together with a corresponding amount in relation to cost of sales. It is intended that revenues and cost of sales for that year will be restated in the forthcoming Report and Accounts for the year ended 31 March 2019. The error arose through a failure to eliminate inter-company sales and attendant costs and additional checks have been added to the internal review and audit processes which are designed to prevent the such a recurrence.

 

 

Commenting, Faisal Rahmatallah, Chairman, said: "We are pleased to report continued strong organic growth across the business over the last financial year, despite the capacity constraints faced in the Films Division. The Industrial Division has enjoyed a good FY2018-19; in particular, the bearings business has performed well and its prospects are good going forward. In the Films Division, small delays to capacity expansion projects have restricted profit growth relative to expectations over the last six months. We enter the new financial year with these projects concluded and we now have an excellent platform in the Films Division for profit growth to resume. We continue to focus on organic growth opportunities across the business as we enter FY2019-20."

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information, please contact:

 

Synnovia plc

Tel: 020 7978 0574

Faisal Rahmatallah, Chairman

Nick Ball, Finance Director

Cenkos Securities

Tel: 020 7397 8900

(Nomad and joint broker)

Mark Connelly

Callum Davidson

Allenby Capital Limited

Tel: 020 3328 5656

(Joint broker)

David Hart

 

Notes to Editors

Synnovia is a specialist manufacturer of industrial components and consumables. Applications for these products vary widely and examples include:

· Packaging for the food manufacturing and distribution - films, sacks and pouches

· Steering columns and instrument control knobs in the automotive industry - plastic ball bearings

· Hydraulic and industrial rubber hose manufacture - various types of plastic mandrel

· Cardboard box manufacture - creasing matrices

 

Synnovia's business model is based on understanding customers' problems in depth, and then developing and mass producing proprietary, technical solutions for these problems.

 

The business operates through two divisions, Films and Industrial, and has the majority of its production in six UK based factories, with a further two factories in Asia. Approximately 50% of its £83 million sales are made outside the UK to more than 80 countries.

 

Further information can be found on www.synnoviaplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFIDSTISFIA
Date   Source Headline
9th Apr 20247:00 amRNSConversion of Loan Notes and TVR
2nd Apr 20247:00 amRNSAppointment of Executive Director
14th Mar 20247:00 amRNSInterim Financial Report
11th Mar 20247:00 amRNSFinancing Update
16th Feb 20247:00 amRNSResults of General Meeting
14th Feb 20242:27 pmRNSFinalisation of Cambay Field Farm Out and JV
31st Jan 20249:21 amRNSCambay Farm Out Update
25th Jan 20247:00 amRNSAddendum to the Notice of General Meeting
22nd Jan 20247:00 amRNSCambay Farm Out Update
15th Jan 20247:00 amRNSGM - Notice of Meeting
18th Dec 20238:05 amRNSCambay Farm Out and C-77H Update
18th Dec 20237:00 amRNSUpdate to Admission Date
5th Dec 20237:00 amRNSCambay Farm-Out and Funding Arrangements & TVR
16th Nov 20237:00 amRNSResults of Annual General Meeting
3rd Nov 20237:05 amRNSCambay C-77H Artificial Lift Update
23rd Oct 20238:38 amRNSAGM - Notice of Meeting
25th Sep 202312:48 pmRNSCambay C-77H Workover Update
21st Sep 20237:00 amRNSAnnual Report 2023
14th Sep 20237:00 amRNSInvestor Presentation
8th Sep 20237:00 amRNSChange of Company Secretary
23rd Aug 20239:05 amRNSCambay C-77H Workover Update
8th Aug 202311:32 amRNSPlacement – Issue of Securities and TVR
26th Jul 20237:00 amRNSCambay C-77H Workover Update
25th Jul 202310:52 amRNSCambay C-77H Workover Funding Secured and TVR
4th Jul 20237:00 amRNSCambay C-77H Artificial Lift Update
29th Jun 20237:00 amRNSAppointment of Joint Broker / Board Amendments
27th Jun 202310:17 amRNSUK CCS License Applications
1st Jun 20237:00 amRNSCambay C-77H Artificial Lift Update
18th May 202312:27 pmRNSUK CCS License Applications
28th Apr 20237:00 amRNSChange of Registered Office
26th Apr 20233:35 pmRNSUpdate on Farm Out Process
13th Apr 20237:00 amRNSCambay Update
4th Apr 20237:00 amRNSIssue of Options
15th Mar 20237:00 amRNSInterim Financial Report
9th Mar 20237:00 amRNSCambay C-77H Artificial Lift Update
27th Feb 20237:00 amRNSCambay Farm Out and CCS Update
23rd Feb 20234:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20234:35 pmRNSPrice Monitoring Extension
23rd Feb 20232:05 pmRNSSecond Price Monitoring Extn
23rd Feb 20232:00 pmRNSPrice Monitoring Extension
22nd Feb 20237:00 amRNSConvertible Loan Agreement
1st Feb 20237:00 amRNSCambay C-77H Update
30th Jan 20234:40 pmRNSSecond Price Monitoring Extn
30th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20237:00 amRNSCambay CCS Scheme Presentation
23rd Dec 20227:00 amRNSUpdate - Removal from the Official List of the ASX
13th Dec 20227:00 amRNSShareholder Presentation
1st Dec 20227:00 amRNSCambay PSC Update
29th Nov 202212:50 pmRNSUpdate - Formal request for removal from ASX
23rd Nov 20228:50 amRNSResult of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.